Full coverage · 4 sources

Korea warns of rare vision-loss risk linked to GLP-1 drugs

First reported 21 hours ago · updated 40 min ago. Compare how different outlets cover the same story.

Business · Asian

Korea warns of rare vision-loss risk linked to GLP-1 drugs

The Ministry of Food and Drug Safety issued a safety alert Wednesday to medical professionals and patients over a potential risk of a rare eye condition associated with GLP-1 obesity drugs, including popular obesity treatments Wegovy and Mounjaro.

Korea Times 40 min ago 4 sources 1 min read

How the story developed

10 Nov, 07:52 UTC CNBC: FDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepbound
10 Nov, 11:58 UTC Gulf Insider (Bahrain): “Consider Discontinuing”: FDA Slaps “Eye Stroke” Warning On All GLP-1 Weight-Loss Drugs
10 Nov, 13:10 UTC Fox Business: FDA orders new warning labels on Ozempic, Wegovy over rare risk of permanent vision loss
11 Nov, 04:22 UTC Korea Times: Korea warns of rare vision-loss risk linked to GLP-1 drugs

Every outlet's version

CNBC 1 story

Business

FDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepbound

21 hours ago

Gulf Insider (Bahrain) 1 story

Business · Middle East

“Consider Discontinuing”: FDA Slaps “Eye Stroke” Warning On All GLP-1 Weight-Loss Drugs

17 hours ago

Fox Business 1 story

Business · North America

FDA orders new warning labels on Ozempic, Wegovy over rare risk of permanent vision loss

15 hours ago

Korea Times 1 story

Business · Asian

Korea warns of rare vision-loss risk linked to GLP-1 drugs

40 min ago

News

Business

National

Discover

Korea warns of rare vision-loss risk linked to GLP-1 drugs

Korea warns of rare vision-loss risk linked to GLP-1 drugs

How the story developed

Every outlet's version

CNBC 1 story

FDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepbound

Gulf Insider (Bahrain) 1 story

“Consider Discontinuing”: FDA Slaps “Eye Stroke” Warning On All GLP-1 Weight-Loss Drugs

Fox Business 1 story

FDA orders new warning labels on Ozempic, Wegovy over rare risk of permanent vision loss

Korea Times 1 story

Korea warns of rare vision-loss risk linked to GLP-1 drugs